470 related articles for article (PubMed ID: 19752607)
1. Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy.
Ozden C; Oztekin CV; Ugurlu O; Gokkaya S; Yaris M; Memis A
Urol Int; 2009; 83(2):146-50. PubMed ID: 19752607
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
3. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
[TBL] [Abstract][Full Text] [Related]
4. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
[TBL] [Abstract][Full Text] [Related]
5. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
[TBL] [Abstract][Full Text] [Related]
7. Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7.
Serkin FB; Soderdahl DW; Cullen J; Chen Y; Hernandez J
Urol Oncol; 2010; 28(3):302-7. PubMed ID: 19117774
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer volume at biopsy predicts clinically significant upgrading.
Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA
J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180
[TBL] [Abstract][Full Text] [Related]
9. Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer?
Stav K; Judith S; Merald H; Leibovici D; Lindner A; Zisman A
Urol Oncol; 2007; 25(5):383-6. PubMed ID: 17826654
[TBL] [Abstract][Full Text] [Related]
10. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
Palisaar RJ; Noldus J; Graefen M; Erbersdobler A; Haese A; Huland H
Eur Urol; 2005 Feb; 47(2):176-84. PubMed ID: 15661411
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
[TBL] [Abstract][Full Text] [Related]
12. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
[TBL] [Abstract][Full Text] [Related]
13. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
Boorjian SA; Bianco FJ; Scardino PT; Eastham JA
BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
[TBL] [Abstract][Full Text] [Related]
14. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
Chun FK; Steuber T; Erbersdobler A; Currlin E; Walz J; Schlomm T; Haese A; Heinzer H; McCormack M; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2006 May; 49(5):820-6. PubMed ID: 16439050
[TBL] [Abstract][Full Text] [Related]
15. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
Chun FK; Briganti A; Shariat SF; Graefen M; Montorsi F; Erbersdobler A; Steuber T; Salonia A; Currlin E; Scattoni V; Friedrich MG; Schlomm T; Haese A; Michl U; Colombo R; Heinzer H; Valiquette L; Rigatti P; Roehrborn CG; Huland H; Karakiewicz PI
BJU Int; 2006 Aug; 98(2):329-34. PubMed ID: 16879673
[TBL] [Abstract][Full Text] [Related]
16. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.
Rajinikanth A; Manoharan M; Soloway CT; Civantos FJ; Soloway MS
Urology; 2008 Jul; 72(1):177-82. PubMed ID: 18279938
[TBL] [Abstract][Full Text] [Related]
17. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M
Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846
[TBL] [Abstract][Full Text] [Related]
18. Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL; Freedland SJ
J Urol; 2006 Dec; 176(6 Pt 1):2453-8; discussion 2458. PubMed ID: 17085127
[TBL] [Abstract][Full Text] [Related]
19. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS
BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
[TBL] [Abstract][Full Text] [Related]
20. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.
Rodriguez-Covarrubias F; Larre S; De La Taille A; Abbou CC; Salomon L
BJU Int; 2008 Feb; 101(3):305-7. PubMed ID: 17941921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
